John Michael Kaczmar

Title
InstitutionMedical University of South Carolina
DepartmentHematology/Oncology
AddressP.O. Box MSC 635
Phone843-792-4271
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Graboyes EM, Sterba KR, Li H, Warren GW, Alberg AJ, Calhoun EA, Nussenbaum B, McCay J, Marsh CH, Osazuwa-Peters N, Neskey DM, Kaczmar JM, Sharma AK, Harper J, Day TA, Hughes-Halbert C. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 Mar 10; OP2000943. PMID: 33689399.
      Citations:    
    2. Yan F, Li H, de Almeida JR, Kaczmar JM, Pipkorn P, Zenga J, Richardson MS, Neskey DM, Sharma AK, Day TA, Graboyes EM. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 Feb 23; 194599821989637. PMID: 33618570.
      Citations:    
    3. Yan F, Li H, Kaczmar JM, Sharma AK, Day TA, Neskey DM, Pipkorn P, Zenga J, Graboyes EM. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119. PMID: 32790830.
      Citations:    
    4. Donaldson LB, Yan F, Morgan PF, Kaczmar JM, Fernandes JK, Nguyen SA, Jester RL, Day TA. Hobnail variant of papillary thyroid carcinoma: a systematic review and meta-analysis. Endocrine. 2021 Apr; 72(1):27-39. PMID: 33025563.
      Citations:    
    5. Sion AM, Milburn L, Kaczmar JM. Montelukast-Based Premedication Regimen for Recurrent Cetuximab Infusion-Related Reactions. JCO Oncol Pract. 2021 01; 17(1):54-56. PMID: 32991261.
      Citations:    
    6. Graboyes EM, Halbert CH, Li H, Warren GW, Alberg AJ, Calhoun EA, Nussenbaum B, Marsh CH, McCay J, Day TA, Kaczmar JM, Sharma AK, Neskey DM, Sterba KR. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432. PMID: 32853120.
      Citations:    
    7. Yan F, Knochelmann HM, Morgan PF, Kaczmar JM, Neskey DM, Graboyes EM, Nguyen SA, Ogretmen B, Sharma AK, Day TA. The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020. Cancers (Basel). 2020 Jun 11; 12(6). PMID: 32545409.
      Citations:    
    8. Stafford M, Kaczmar J. The neoadjuvant paradigm reinvigorated: a review of pre-surgical immunotherapy in HNSCC. Cancers Head Neck. 2020; 5:4. PMID: 32195008.
      Citations:    
    9. Kalmuk J, Puchalla J, Feng G, Giri A, Kaczmar J. Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge. Cancers Head Neck. 2020; 5:3. PMID: 32025343.
      Citations:    
    10. Graboyes EM, Ellis MA, Li H, Kaczmar JM, Sharma AK, Lentsch EJ, Day TA, Hughes Halbert C. Racial and Ethnic Disparities in Travel for Head and Neck Cancer Treatment and the Impact of Travel Distance on Survival. Cancer. 2018 08 01; 124(15):3181-3191. PMID: 29932220.
      Citations:    
    11. Ellis MA, Graboyes EM, Wahlquist AE, Neskey DM, Kaczmar JM, Schopper HK, Sharma AK, Morgan PF, Nguyen SA, Day TA. Primary Surgery vs Radiotherapy for Early Stage Oral Cavity Cancer. Otolaryngol Head Neck Surg. 2018 04; 158(4):649-659. PMID: 29256326.
      Citations:    
    12. Beck TN, Kaczmar J, Handorf E, Nikonova A, Dubyk C, Peri S, Lango M, Ridge JA, Serebriiskii IG, Burtness B, Golemis EA, Mehra R. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck. Oncotarget. 2015 Aug 07; 6(22):18863-74. PMID: 26265441.
      Citations:    
    13. Kaczmar J, Mehra R. The efficacy of ceritinib in patients with ALK-positive non-small cell lung cancer. Ther Adv Respir Dis. 2015 Oct; 9(5):236-41. PMID: 26229087.
      Citations:    
    14. Kaczmar JM, Tan KS, Heitjan DF, Lin A, Ahn PH, Newman JG, Rassekh CH, Chalian AA, O'Malley BW, Cohen RB, Weinstein GS. HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head Neck. 2016 Jan; 38(1):59-65. PMID: 25197014.
      Citations:    
    15. Kaczmar J, Mehra R. HPV-negative head and neck squamous cell carcinomas: how can we use the tumor protein signature? Biomark Med. 2015; 9(3):183-5. PMID: 25731205.
      Citations:    
    Kaczmar's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (54)
    Explore
    _
    Co-Authors (13)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _